Manufacturing / Pharmaceutical Preparations
AbbVie Inc.
ABBV
$245.51
-$1.30 (-0.53%)
Price as of Aug 5, 2026 13:11 UTC
370 B
Market Cap (Mega Cap)
60%
IV Rank
28.5%
Implied Volatility
Oct 29
Next Earnings
Technical Signals
as of Aug 3
Mixed
3 of 7
Trend
- Above 20-day average $251.90
- Above 50-day average $241.02
- Above 200-day average $226.13 · +8.4%
- Moving averages stacked 20 > 50 > 200
Momentum
- Golden cross (50/200) 25d ago
- Momentum cross (20/50) 43d ago
Volume
- Below-average volume 1.2x avg
Price & Trend
Daily candles with EMA 20, SMA 50. Drag to zoom.
Options Activity & Greeks
Implied volatility, flow, and dealer positioning from the options market.
Put/Call Ratio
0.77
Bullish skew
Implied Volatility
28.5%
1% percentile
IV vs Realized
Options cheap
20d HV 29.3%
Options Heat Map
Delta-risk grid for ABBV options across strikes and expirations. Hover any cell for full Greeks.
Loading option chain data...
Insider Trades
0 buys
8 sells
| Date | Insider | Title | Type | Shares | Value |
|---|---|---|---|---|---|
| Jun 30, 2026 | RAPP EDWARD J | Grant | 134 | $33,720 | |
| Jun 30, 2026 | Quaggin Susan E | Grant | 62 | $15,602 | |
| May 08, 2026 | Hart Brett J | Grant | 1,118 | $0 | |
| May 08, 2026 | Roberts Rebecca B | Grant | 1,118 | $0 | |
| May 08, 2026 | FREYMAN THOMAS C | Grant | 1,118 | $0 | |
| May 08, 2026 | WADDELL FREDERICK H | Grant | 1,118 | $0 | |
| May 08, 2026 | FALK THOMAS J | Grant | 1,118 | $0 | |
| May 08, 2026 | RAPP EDWARD J | Grant | 1,118 | $0 | |
| May 08, 2026 | AUSTIN ROXANNE S | Grant | 1,118 | $0 | |
| May 08, 2026 | Quaggin Susan E | Grant | 1,118 | $0 |
Politician Trades in ABBV
| Date | Politician | Party | Type | Amount |
|---|---|---|---|---|
| May 05, 2026 | Josh S. Gottheimer | D | Sale | $1K-$15K |
| Apr 13, 2026 | Ro Khanna | D | Sale | $15K-$50K |
| Mar 30, 2026 | Ro Khanna | D | Sale | $15K-$50K |
| Feb 05, 2026 | Ro Khanna | D | Purchase | $15K-$50K |
| Dec 18, 2025 | Julie Johnson | D | Sale | $1K-$15K |
| Dec 08, 2025 | Julia Letlow | R | Sale | $1K-$15K |
| Nov 13, 2025 | Julie Johnson | D | Sale | $1K-$15K |
| Oct 31, 2025 | Lisa C. McClain | R | Sale | $1K-$15K |
| Oct 30, 2025 | Lisa C. McClain | R | Sale | $1K-$15K |
| Oct 30, 2025 | Lisa C. McClain | R | Purchase | $1K-$15K |
Earnings History
| Date | Quarter | EPS Est. | EPS Actual | Surprise | Result |
|---|---|---|---|---|---|
| Jul 31, 2026 | Q2 2026 | $3.68 | |||
| Jul 29, 2026 | Q2 2026 | $3.84 | |||
| Jul 24, 2026 | Q2 2026 | $3.84 | |||
| Jun 30, 2026 | Q2 2026 | $3.68 | $3.65 | -0.7% | Miss |
| Mar 31, 2026 | Q1 2026 | $2.65 | $2.65 | +0.2% | Beat |
| Dec 31, 2025 | Q4 2025 | $2.71 | $2.71 | +0.2% | Beat |
| Sep 30, 2025 | Q3 2025 | $1.81 | $1.86 | +2.7% | Beat |
| Jun 30, 2025 | Q2 2025 | $2.94 | $2.97 | +0.9% | Beat |
Track ABBV with ThetaPal
Get insider trade alerts, AI portfolio analysis, and options roll recommendations for ABBV and your entire portfolio.